Skip to main content
SpringerLink
Log in

Acute kidney injury following acute liver failure: potential role of systemic cadmium mobilization?

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

A significant fraction of patients with acute liver failure (ALF) suffer from a concomitant acute kidney injury (AKI), the mechanism of which is probably multifactorial. Cadmium (Cd) is a widespread environmental pollutant and a tubulotoxic metal that accumulates in the liver. We tested the hypothesis that a release of Cd during ALF may cause a redistribution of Cd from the liver to the kidneys and play a role in the occurrence of ALF-associated AKI.

Methods

Twenty patients with ALF (ALF-patients), 20 patients from the ICU with no liver damage at admission (ICU-controls) and 20 healthy controls were recruited to compare the 24-h urinary excretion rate of Cd with that of lead (Pb), a nephrotoxic metal that does not accumulate in the liver, and zinc (Zn), a non-nephrotoxic element found in high amounts in the liver. The excretion rates of the low-molecular-weight proteins (LMWPs) were monitored.

Results

ALF-patients excreted markedly more Cd than the healthy controls and ICU-controls. In ALF-patients, the four urinary LMWPs (RBP, β2-MG, CC16 and α1-MG) increased as a function of Cd excretion, with high correlation coefficients. The prevalence of patients excreting a high amount of LMWPs also increased with increasing Cd excretion. No relationship was found between the other elements investigated and the LMWPs, with the exception of copper, which shares close toxicokinetic similarities with Cd.

Conclusions

This study shows a strong association between urinary Cd levels and the excretion rates of LMWPs in patients with ALF. A causal relationship is possible but could not be fully demonstrated in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. McKinnell J, Holt S (2007) Liver disease and renal dysfunction. Medicine 35:521–523

    Article  Google Scholar 

  2. Moore K (1999) Renal failure in acute liver failure. Eur J Gastroenterol Hepatol 11:967–975

    Article  PubMed  CAS  Google Scholar 

  3. Eguia L, Materson BJ (1997) Acetaminophen-related acute renal failure without fulminant liver failure. Pharmacotherapy 17:363–370

    PubMed  CAS  Google Scholar 

  4. Hengy B, Hayi-Slayman D, Page M, Christin F, Baillon JJ, Ber CE, Allaouchiche B, Rimmelé T (2009) Acute renal failure after acetaminophen poisoning: report of three cases. Can Anaesth 56:770–774

    Article  Google Scholar 

  5. Mazer M, Perrone J (2008) Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol 4:2–6

    Article  PubMed  Google Scholar 

  6. Wilkinson SP, Moodie H, Arroyo VA, Williams R (1977) Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. J Clin Pathol 30:141–143

    Article  PubMed  CAS  Google Scholar 

  7. Jarup L, Akesson A (2009) Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238:201–208

    Article  PubMed  Google Scholar 

  8. U.S. Geological Survey (2009) U.S. Geological Survey mineral commodity summaries, January 2009. Available at: http://minerals.usgs.gov/minerals/pubs/commodity/cadmium/mcs-2009-cadmi.pdf. Accessed 1 Dec 2011

  9. European Chemicals Bureau (2007) European Union risk assessment report cadmium metal and cadmium oxide. Office for Official Publications of the European Communities, vol 74. EUR 22767 EN. European Union, Luxembourg

  10. Cain K, Griffiths B (1980) Transfer of liver cadmium to the kidney after aflatoxin induced liver damage. Biochem Pharmacol 29:1852–1855

    Article  PubMed  CAS  Google Scholar 

  11. Chan HM, Zhu LF, Zhong R, Grant D, Goyer RA, Cherian MG (1993) Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats. Toxicol Appl Pharmacol 123:89–96

    Article  PubMed  CAS  Google Scholar 

  12. Bernard AM, Lauwerys RR (1981) The effects of sodium chromate and carbon tetrachloride on the urinary excretion and tissue distribution of cadmium in cadmium-pretreated rats. Toxicol Appl Pharmacol 57:30–38

    Article  PubMed  CAS  Google Scholar 

  13. Vanderperren B, Rizzo M, Angenot L, Haufroid V, Jadoul M, Hantson P (2005) Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 39:1353–1357

    Article  PubMed  Google Scholar 

  14. Bernuau J, Rueff B, Benhamou JP (1986) Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6:97–106

    Article  PubMed  CAS  Google Scholar 

  15. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute kidney injury network (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31

    Article  PubMed  Google Scholar 

  16. Bernard A, Lauwerys RR (1983) Continuous flow system for the automation of latex immunoassay. Clin Chem 29:1007–1011

    PubMed  CAS  Google Scholar 

  17. Lauwerys R, Hoet P (2001) Industrial chemical exposure: guidelines for biological monitoring. 3rd edn. Lewis Publ, Boca Raton

  18. Finn W, Porter G (2008) Urinary biomarkers and nephrotoxicity. In: De Broe M, Porter G (eds) Clinical nephrotoxins. Renal injury from drugs and chemicals, 3rd edn. Springer, New York, pp 91–130

    Google Scholar 

  19. Bernard A (2004) Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 17:519–523

    Article  PubMed  CAS  Google Scholar 

  20. Nordberg GF, Kido T, Roels H (2008) Cadmium-induced renal effects. In: De Broe M, Porter G (eds) Clinical nephrotoxins. Renal injury from drugs and chemicals, 3rd edn. Springer, New York, pp 785–810

    Google Scholar 

  21. EL-Safty IAM, Afifi AMH, Shouman AE, EL-Sady AKR (2004) Effects of smoking and lead exposure on proximal tubular integrity among egyptian industrial workers. Arch Med Res 35:59–65

    Article  PubMed  CAS  Google Scholar 

  22. Melichar B, Jandik P, Malir F, Vavrova J, Bures J, Mergancova J, Voboril Z (1995) Association between renal tubular cell dysfunction and increased urinary zinc excretion in cancer patients. Scand J Clin Lab Invest 55:149–152

    Article  PubMed  CAS  Google Scholar 

  23. Yuzbasiyan-Gurkan VA, Brewer GJ, Vander AJ, Guenther MJ, Prasad AS (1989) Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia. Am J Hematol 31:87–90

    Article  PubMed  CAS  Google Scholar 

  24. Dorian C, Gattone VH, Klaassen CD (1995) Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules. Toxicol Appl Pharmacol 130:161–168

    Article  PubMed  CAS  Google Scholar 

  25. Vestergaard P, Shaikh ZA (1994) The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden. Toxicol Appl Pharmacol 126:240–247

    Article  PubMed  CAS  Google Scholar 

  26. Liu J, Habeebu SS, Liu Y, Klaassen CD (1998) Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats. Toxicol Appl Pharmacol 153:48–58

    Article  PubMed  CAS  Google Scholar 

  27. Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M (1998) Health effects of cadmium exposure—a review of the literature and a risk estimate. Scand J Work Environ Health 24[Suppl]1:1–51

    Google Scholar 

  28. Bem EM, Piotrowski JK, Sobczak-Kozlowska M, Dmuchowski C (1988) Cadmium, zinc, copper and metallothionein levels in human liver. Int Arch Occup Environ Health 60:413–417

    Article  PubMed  CAS  Google Scholar 

  29. Orlowski C, Piotrowski JK (1998) Metal composition of human hepatic and renal metallothionein. Biol Trace Elem Res 65:133–141

    Article  PubMed  CAS  Google Scholar 

  30. Dudley RE, Gammal LM, Klaassen CD (1985) Cadmium-induced hepatic and renal injury in chronically exposed rats: likely role of hepatic cadmium-metallothionein in nephrotoxicity. Toxicol Appl Pharmacol 77:414–426

    Article  PubMed  CAS  Google Scholar 

  31. Nomiyama K, Nomiyama H, Kameda N (1998) Plasma cadmium-metallothionein, a biological exposure index for cadmium-induced renal dysfunction, based on the mechanism of its action. Toxicology 129:157–168

    Article  PubMed  CAS  Google Scholar 

  32. Tanaka K (1982) Effects of hepatic disorder on the fate of cadmium in rats. Dev Toxicol Environ Sci 9:237–249

    PubMed  CAS  Google Scholar 

  33. Nakajima M, Kobayashi E, Suwazono Y, Uetani M, Oishi M, Inaba T, Kido T, Shaikh ZA, Nogawa K (2005) Excretion of urinary cadmium, copper, and zinc in cadmium-exposed and nonexposed subjects, with special reference to urinary excretion of beta2-microglobulin and metallothionein. Biol Trace Elem Res 108:17–31

    Article  PubMed  CAS  Google Scholar 

  34. Ikeda M, Ohashi F, Fukui Y, Takada S, Moriguchi J, Ezaki T (2007) Changes in tubular dysfunction marker levels in parallel with the levels of copper, rather than cadmium, in urine of middle-aged women in non-polluted areas. Int Arch Occup Environ Health 80:171–183

    Article  PubMed  CAS  Google Scholar 

  35. Nomiyama K, Nomiyama H, Kameda N, Tsuji A, Sakurai H (1999) Mechanism of hepatorenal syndrome in rats of Long–Evans Cinnamon strain, an animal model of fulminant Wilson’s disease. Toxicology 132:201–214

    Article  PubMed  CAS  Google Scholar 

  36. Lin JL, Lin-Tan DT, Chu PH, Chen YC, Huang YL, Ho TC, Lin CY (2009) Cadmium excretion predicting hospital mortality and illness severity of critically ill medical patients. Crit Care Med 37:957–962

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Louvain Centre for Toxicology and Applied Pharmacology, Brussels, Belgium

    Perrine Hoet, Vincent Haufroid, Gladys Deumer, Xavier Dumont, Dominique Lison & Philippe Hantson

  2. Department of Intensive Care, Cliniques St-Luc, Université catholique de Louvain, Avenue Hippocrate, 10, 1200, Brussels, Belgium

    Philippe Hantson

Authors
  1. Perrine Hoet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincent Haufroid
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gladys Deumer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xavier Dumont
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dominique Lison
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Philippe Hantson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philippe Hantson.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (JPEG 37 kb)

Supplementary material 2 (JPEG 55 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoet, P., Haufroid, V., Deumer, G. et al. Acute kidney injury following acute liver failure: potential role of systemic cadmium mobilization?. Intensive Care Med 38, 467–473 (2012). https://doi.org/10.1007/s00134-011-2449-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-011-2449-0

Keywords

Search

Navigation